The Myeloma 2016 meeting: Integrating science and clinical practice
Features of high-risk multiple myeloma and how to treat it
Can venetoclax be used to treat multiple myeloma (MM)?
Are we ready to use minimal residual disease (MRD) to direct multiple myeloma therapy?
Overview of a promising new study of venetoclax in patients with CLL